Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Health Canada clears phase III ReoT3D trial in head and neck cancer

July 20, 2010

FDA approves Lorus Therapeutics' IND for anticancer agent LOR-253

July 20, 2010

Amgen's denosumab BLA receives FDA priority review status

July 19, 2010

Chinese scientists identify novel protein kinase inhibitors

July 19, 2010

Merck KGaA identifies new tyrosine kinase inhibitors

July 16, 2010

FDA grants orphan drug status to Keryx's perifosine for neuroblastoma

July 16, 2010

Vertex scientists present new ATR kinase inhibitors

July 16, 2010

ChemGenex to submit new NDA for Omapro as third-line CML therapy

July 15, 2010

Peregrine begins second phase IIb trial of bavituximab in NSCLC

July 15, 2010

Linifanib/mFOLFOX6 combination shows promise in metastatic colorectal cancer

July 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...